Back to Trades
Sell4
Acumen Pharmaceuticals, Inc.
ABOS
Total Value
$63.1K
Net $28.3K sold
Sales
$28.3K
1 transaction
Company Information
- Company Name
- Acumen Pharmaceuticals, Inc.
- Ticker Symbol
- ABOS
- CIK
- 0001576885
Insider Information
- Name
- Meisner Derek M
- Role
- Chief Legal Officer & Corp Sec
- Location
- NEWTON, MA
Officer
Filing Details
- Filing Date
- Mar 3, 2026
- Transaction Date
- Feb 27, 2026
- Accession Number
- 0001628280-26-014365
- Form Type
- 4
- Net Trading Amount
- -$28.3K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Feb 27, 2026 | Common Stock | 9,406 | $1.85 | Exercise | $17.4K |
| Feb 27, 2026 | Common Stock | 9,406 | $3.01 | Sale | $28.3K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Feb 27, 2026 | Derivative | 9,406 | $1.85 | Exercise | $17.4K |
Footnotes
- (F1)The reported sales occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 29, 2025.
- (F2)The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $3.0000 to $3.0300. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- (F3)The shares subject to the employee stock option vest in 48 equal monthly installments starting on the date the option was granted, such that the option will be fully vested on the fourth anniversary of the date of grant, subject to the Reporting Person's continuous service through each such vesting date.